Join ASA as Founder Steph Sherer shares insights about the recent Cannabis & Scheduling headlines including what’s next in the scheduling process, what Schedule II & III status means for patients, and why we need to prepare for the impact!
 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 
Americans for Safe Access: Advancing Legal
Medical Cannabis Therapeutics

Hello Friend,

I am sure you have lots of questions about what Schedule III means for patients. ASA's recent blog may address some of your questions.   “It’s Time for Medical Cannabis Patients to Step into the spotlight!

But the big take away from rescheduling, is it is time for patients to act!

Chances are your federal representatives aren’t sure what rescheduling means for patients unless YOU tell them: Act Now!

https://www.safeaccessnow.org/roadmap_to_rescheduling

On Sunday, May 5th at 2 PM EST/11 AM PST, join us for "Emergency Meeting: How to Respond to Schedule III". We'll delve into recent cannabis and scheduling headlines, discuss what's next in the scheduling process, and shed light on what Schedule II & III status means for patients. It's an opportunity to prepare for the impact and shape the future of medical cannabis.


This is a big deal, let’s make it count!

See you Sunday,

Steph Sherer

PS: "Cannabis has accepted medical use for treatment in the United States." (Go ahead, say it out loud)

ASA needs your support to ensure this statement isn't just a proclamation but a promise fulfilled!

DONATE NOW!

Facebook Twitter LinkedIn Instagram Website

Americans for Safe Access · 1629 K St NW, Suite 300, Washington, DC 20006-1631, United States
This email was sent to [email protected] · Unsubscribe